www.fdanews.com/articles/97775-idera-pharmaceuticals-announces-issuance-of-u-s-patent-for-novel-immunostimulatory-oligonucleotide-compositions
Idera Pharmaceuticals Announces Issuance of U.S. Patent for Novel Immunostimulatory Oligonucleotide Compositions
August 29, 2007
Idera Pharmaceuticals, Inc. announced the issuance of U.S. patent 7,262,286 (the ‘286 patent) for novel immunostimulatory oligonucleotide compositions.
Idera